(Q54383762)
Statements
Combination use of anti-CD133 antibody and SSA lectin can effectively enrich cells with high tumorigenicity (English)
Kenta Moriwaki
Kumiko Okudo
Naotsugu Haraguchi
Shunsaku Takeishi
Masahiro Tanemura
Hideshi Ishii
Masaki Mori
Eiji Miyoshi
14 April 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference